Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
49.9M
Number of holders
61
Total 13F shares, excl. options
26.4M
Shares change
+1.94M
Total reported value, excl. options
$436M
Value change
+$31.7M
Number of buys
31
Number of sells
-20
Price
$16.53

Significant Holders of HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) as of Q1 2023

64 filings reported holding HLVX - HilleVax, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.4M shares of 49.9M outstanding shares and own 52.96% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (9.78M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.83M shares), Carlyle Group Inc. (1.84M shares), RA CAPITAL MANAGEMENT, L.P. (1.76M shares), BRAIDWELL LP (1.62M shares), FRANKLIN RESOURCES INC (1.28M shares), T. Rowe Price Investment Management, Inc. (1.21M shares), BlackRock Inc. (1.04M shares), StepStone Group LP (677K shares), and Samsara BioCapital, LLC (610K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.